|
* Latest "Diagnostics" in the News *
|
FIRE101 Jobs:
FIREMEN, EMS, Emergency, Rescue
|
|
POLICE101 Jobs:
Cops,Officers,Security
|
|
Mainframe IT Jobs:
z/OS, z/VM, DB2, COBOL,QA,INTERNs
|
|
Software Jobs:
Web, Linux, C++, Java, INTERNs
|
|
Finance Jobs:
Accounting, INTERNS, Brokers, Invest
|
|
Legal, Lawyer Jobs:
Paralegals,
INTERNs,Law Firms
|
|
Medical, Nurse Jobs:
Doctors, INTERNs, Nurses, ER
|
|
Genetic, Science Jobs
Genetics, Research,
INTERNs, Labwork
|
|
|
Internet Search Results
Diagnostics - Global - World Health Organization (WHO)
Diagnostics are important to ensure quality, comprehensive and integrated primary health care and health services everywhere and for everyone. Every medical decision depends on a proper diagnosis, and while diagnostics results influence approximately 70% of healthcare decisions, only 3–5% of healthcare budgets go to diagnostic services.
Strengthening diagnostics capacity - World Health Organization (WHO)
Whilst approximately 70% of healthcare decisions are made based on diagnostic test results, only 3–5% of healthcare budgets go to diagnostic services. In many countries clinicians don’t have access to basic diagnostic tools or laboratory tests needed to support patients. When they are available, vast distances and isolated communities often make testing people extremely difficult ...
WHO publishes new Essential Diagnostics List and urges countries to ...
To address the lack of access to tests and testing services in multiple countries, WHO since 2018 has published a yearly essential diagnostics list (EDL), a basket of recommended in vitro diagnostics that should be available at point-of-care and in laboratories in all countries to increase timely and life-saving diagnoses. The latest edition, published today, includes WHO-recommended COVID-19 ...
WHO lists additional mpox diagnostic tests for emergency use
The status of active applications and listed mpox diagnostics under WHO EUL procedure can be seen on WHO webpages. After WHO Director-General Dr Tedros Adhanom Ghebreyesus declared mpox a public health emergency of international concern (PHEIC) on 14 August 2024, WHO called on mpox in vitro diagnostic manufacturers to submit expressions of ...
Analysis of TB R&D pipeline - World Health Organization (WHO)
A high-level summary of the status of the pipelines for new TB diagnostics, drugs and vaccines in active development, as of September 2023 is further summarized here. Over all: The diagnostic pipeline has expanded considerably in terms of the number of tests, products or methods in development.
2.2 Diagnostic testing - World Health Organization (WHO)
An essential step in the pathway of tuberculosis (TB) care is rapid and accurate diagnostic testing. Since 2011, rapid molecular tests that are highly specific and sensitive have transformed the TB diagnostic landscape, which previously relied upon more traditional microscopy and culture me
6. TB research and innovation - World Health Organization (WHO)
TB diagnostics The diagnostic pipeline has continued to expand in terms of the number of diagnostic classes, tests, products and methods in development ( Table 6.1 ). These include new biomarker-based point-of-care (POC) and near-POC test classes, as well as tests in existing diagnostic classes.
First-ever WHO list of essential diagnostic tests to improve diagnosis ...
To address this gap, WHO today published its first Essential Diagnostics List, a catalogue of the tests needed to diagnose the most common conditions as well as a number of global priority diseases. “An accurate diagnosis is the first step to getting effective treatment,” says Dr Tedros Adhanom Ghebreyesus, WHO Director-General.
2.2 Diagnostic testing for TB - World Health Organization (WHO)
Globally in 2022, a WHO-recommended rapid diagnostic test (WRD) was used as the initial diagnostic test for 47% (3.5 million) of the 7.5 million people newly diagnosed with TB in 2022, up from 38% (out of a total of 6.4 million) in 2021 and 33% (out of a total of 5.8 million) in 2020 (Fig. 2.2.5).
WHO urges rapid access to mpox diagnostic tests, invites manufacturers ...
WHO has asked manufacturers of mpox in vitro diagnostics (IVDs) to submit an expression of interest for Emergency Use Listing (EUL). WHO has been in ongoing discussions with manufacturers about the need for effective diagnostics, particularly in low-income settings. The request for EUL expressions of interest by manufacturers is the latest development in these discussions.
|
|
